Our Business Development Manager, Kate Bristow, will be attending the Making Pharma awards on the 29th of April at the Coventry Building Society Arena.
We are delighted to have been nominated for our modified Supercritical Anti-Solvent (mSAS®) particle engineering platform for green manufacturing. This is our second nomination in the area of sustainability this year, following our recent nomination for the Bionow awards. Crystec is nominated alongside AstraZeneca and Veolia Water Technologies in the sustainability in manufacture category. The awards are judged by a distinguished panel of experts from the pharmaceutical industry.
If you would like to talk to Kate at the awards or about our recent nominations, please contact her at kate.bristow@crystecpharma.com